Literature DB >> 12915541

Identification of a mutation in editing of defective Newcastle disease virus recombinants that modulates P-gene mRNA editing and restores virus replication and pathogenicity in chicken embryos.

Teshome Mebatsion1, Leonie T C de Vaan, Niels de Haas, Angela Römer-Oberdörfer, Marian Braber.   

Abstract

Editing of P-gene mRNA of Newcastle disease virus (NDV) enables the formation of two additional proteins (V and W) by inserting one or two nontemplated G residues at a conserved editing site (5'-AAAAAGGG). The V protein of NDV plays an important role in virus replication and is also a virulence factor presumably due to its ability to counteract the antiviral effects of interferon. A recombinant virus possessing a nucleotide substitution within the A-stretch (5'-AAgAAGGG) produced 20-fold-less V protein and, in consequence, was impaired in replication capacity and completely attenuated in pathogenicity for chicken embryos. However, in a total of seven serial passages, restoration of replication and pathogenic capacity in 9- to 11-day-old chicken embryos was noticed. Determining the sequence around the editing site of the virus at passage 7 revealed a C-to-U mutation at the second nucleotide immediately upstream of the 5'-A(5) stretch (5'-GuUAAgAAGGG). The V mRNA increased from an undetectable level at passage 5 to ca. 1 and 5% at passages 6 and 7, respectively. In addition, similar defects in another mutant possessing a different substitution mutation (5'-AAAcAGGG) were restored in an identical manner within a total of seven serial passages. Introduction of the above C-to-U mutation into the parent virus (5'-GuUAAAAAGGG) altered the frequency of P, V, and W mRNAs from 68, 28, and 4% to 15, 44, and 41%, respectively, demonstrating that the U at this position is a key determinant in modulating P-gene mRNA editing. The results indicate that this second-site mutation is required to compensate for the drop in edited mRNAs and consequently to restore the replication capacity, as well as the pathogenic potential, of editing-defective NDV recombinants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915541      PMCID: PMC187413          DOI: 10.1128/jvi.77.17.9259-9265.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  The versatility of paramyxovirus RNA polymerase stuttering.

Authors:  S Hausmann; D Garcin; C Delenda; D Kolakofsky
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; Y Nagai
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

3.  Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; T Shioda; Y Nagai
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Generation of recombinant lentogenic Newcastle disease virus from cDNA.

Authors:  Angela Römer-Oberdörfer; Egbert Mundt; Teshome Mebatsion; Ursula J Buchholz; Thomas C Mettenleiter
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

5.  Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.

Authors:  A P Durbin; J M McAuliffe; P L Collins; B R Murphy
Journal:  Virology       Date:  1999-09-01       Impact factor: 3.616

6.  Sendai viruses with altered P, V, and W protein expression.

Authors:  C Delenda; G Taylor; S Hausmann; D Garcin; D Kolakofsky
Journal:  Virology       Date:  1998-03-15       Impact factor: 3.616

7.  Two nucleotides immediately upstream of the essential A6G3 slippery sequence modulate the pattern of G insertions during Sendai virus mRNA editing.

Authors:  S Hausmann; D Garcin; A S Morel; D Kolakofsky
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo.

Authors:  A Valsamakis; H Schneider; P G Auwaerter; H Kaneshima; M A Billeter; D E Griffin
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

10.  Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis.

Authors:  C Tober; M Seufert; H Schneider; M A Billeter; I C Johnston; S Niewiesk; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

View more
  7 in total

1.  Genomic sequence of an antigenic variant Newcastle disease virus isolated in Korea.

Authors:  Sun-Hee Cho; Sun-Joong Kim; Hyuk-Joon Kwon
Journal:  Virus Genes       Date:  2007-02-21       Impact factor: 2.332

2.  Genetic analysis of avian paramyxovirus-1 (Newcastle disease virus) isolates obtained from swine populations in China related to commonly utilized commercial vaccine strains.

Authors:  Zhuang Ding; Yan-long Cong; Shuang Chang; Guang-mei Wang; Ze Wang; Quan-peng Zhang; Hao Wu; Yu-zhang Sun
Journal:  Virus Genes       Date:  2010-07-27       Impact factor: 2.332

3.  Nipah virus edits its P gene at high frequency to express the V and W proteins.

Authors:  Sachin Kulkarni; Valentina Volchkova; Christopher F Basler; Peter Palese; Viktor E Volchkov; Megan L Shaw
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

4.  Identification of Newcastle disease virus P-gene editing using next-generation sequencing.

Authors:  Xi Chen; Yanqing Jia; Shanhui Ren; Siqi Chen; Xiangwei Wang; Xiaolong Gao; Chongyang Wang; Fathalrhman E A Adam; Xinglong Wang; Zengqi Yang
Journal:  J Vet Med Sci       Date:  2020-07-06       Impact factor: 1.267

5.  Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes.

Authors:  J Fréderique de Graaf; Stefan van Nieuwkoop; Theo Bestebroer; Daphne Groeneveld; Casper H J van Eijck; Ron A M Fouchier; Bernadette G van den Hoogen
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

6.  Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.

Authors:  Michael K Lo; Mark E Peeples; William J Bellini; Stuart T Nichol; Paul A Rota; Christina F Spiropoulou
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

7.  Molecular evolution and genetic variations of V and W proteins derived by RNA editing in Avian Paramyxoviruses.

Authors:  Pachineella Lakshmana Rao; Ravi Kumar Gandham; Madhuri Subbiah
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.